XM does not provide services to residents of the United States of America.

U.S. STOCKS Intel, Abbott, Boeing



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>BUZZ-U.S. STOCKS ON THE MOVE-Intel, Abbott, Boeing</title></head><body>

Eikon search string for individual stock moves: STXBZ

The Day Ahead newsletter: https://refini.tv/3LI4BU7

The Morning News Call newsletter: https://refini.tv/3dKUyB8

U.S. stock index futures slightly pared gains on Friday after job additions in October were much lower than estimated, while the unemployment rate remained steady. .N


At 8:20 ET, Dow e-minis 1YMc1 were up 0.34% at 42,088. S&P 500 e-minis ESc1 were up 0.41% at 5,761.75, while Nasdaq 100 e-minis NQc1 were up 0.47% at 20,116.

The top three NYSE percentage gainers premarket .PRPG.NQ:
** Proto Labs PRLB.N, up 17.2%
** Wayfair W.N, up 10.7%
** Cooper-Standard Holdings CPS.N, up 9.7%

The top three NYSE percentage losers premarket .PRPL.NQ:
** DigitalBridge Group DBRG.N, down 7.6%
** Energy Vault NRGV.N, down 5.9%
** Solarwinds SWI.N, down 5%

The top three Nasdaq percentage gainers premarket .PRPG.O:
** Athira Pharma Inc ATHA.O, up 52.8%
** VS Media Holdings VSME.O, up 31.9%
** Pro-Dex PDEX.O, up 23.9%

The top three Nasdaq percentage losers premarket .PRPL.O:
** CompanEssa Pharma Inc EPIX.O, down 70%
** Lexicon Pharmaceuticals LXRX.O, down 33.8%

** Elevai Labs ELAB.O, down 33.1%


** Intel INTC.O: up 7.2% premarket
BUZZ - Rises after upbeat Q4 forecast fuels recovery hopes nL4N3M810L


** Chevron CVX.N: up 1.7% premarket
BUZZ - Rises on Q3 profit beat nL4N3M816J


** Abbott Laboratories ABT.N: up 5.2% premarket
BUZZ - Climbs on being cleared of liability in latest preterm formula case nL4N3M814R


** William Penn Bancorp WMPN.O: up 3.6% premarket
BUZZ - Surges on $127 mln deal with Mid Penn nL4N3M816K


** Sirius XM Holdings Inc SIRI.O: up 1.0% premarket
BUZZ - Shares rise as Buffett's Berkshire ups stake to 33% nL6N3M80DP


** Exxon Mobil XOM.N: up 1.9% premarket
BUZZ - Climbs as Q3 profit beats on rising production nL4N3M817N


** Halozyme Therapeutics HALO.O: up 12.2% premarket
BUZZ - Rises after raising FY forecast, upbeat Q3 results nL4N3M8157


** Boeing BA.N: up 2.1% premarket
BUZZ - Climbs after it makes improved pay raise offer to striking workers nL4N3M814E


(Compiled by Rajarshi Roy and Rishi Kant)

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.